Author: Perepelkin J, Antunes K, Boechler L, Remillard AJ, Mildenberger L
Conference/Journal: J Am Pharm Assoc (2003).
Date published: 2018 Dec 11
Other:
Pages: S1544-3191(18)30465-5 , Special Notes: doi: 10.1016/j.japh.2018.10.017. [Epub ahead of print] , Word Count: 191
OBJECTIVE: The objective of this study was to assess the impact of mindfulness meditation offered in a community pharmacy on patients with current anxiety or a history of anxiety, depression, or both.
SETTING: Community pharmacy clinical space located in a grocery store.
PRACTICE DESCRIPTION: An 8-week, once-per-week mindfulness meditation program for patients with anxiety or depression.
PRACTICE INNOVATION: A pharmacist provided mindfulness meditation within the clinical space in a community pharmacy.
EVALUATION: PHQ-9 and GAD-7 were used to assess prestudy and poststudy depression and anxiety severity, respectively. Items pertaining to participant demographics and experience in the program were also included.
RESULTS: Twelve participants completed the study requirements. Three-quarters of participants experienced a reduction in the severity of their depression or anxiety, and no participant experienced an increase in the severity of his or her condition.
CONCLUSION: Findings from this study indicated that a mindfulness meditation program delivered in a community pharmacy and provided by a pharmacist for patients with depression or anxiety, or both, can result in a reduction in severity of their conditions for participants.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.
PMID: 30552050 DOI: 10.1016/j.japh.2018.10.017